These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 12589451

  • 21. Reduction of endogenous angiogenesis inhibitors in Bruch's membrane of the submacular region in eyes with age-related macular degeneration.
    Bhutto IA, Uno K, Merges C, Zhang L, McLeod DS, Lutty GA.
    Arch Ophthalmol; 2008 May; 126(5):670-8. PubMed ID: 18474778
    [Abstract] [Full Text] [Related]

  • 22. Fas ligand (CD95 ligand) controls angiogenesis beneath the retina.
    Kaplan HJ, Leibole MA, Tezel T, Ferguson TA.
    Nat Med; 1999 Mar; 5(3):292-7. PubMed ID: 10086384
    [Abstract] [Full Text] [Related]

  • 23. Public health impact of neovascular age-related macular degeneration treatments extrapolated from visual acuity.
    Bandello F, Lafuma A, Berdeaux G.
    Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):96-103. PubMed ID: 17197522
    [Abstract] [Full Text] [Related]

  • 24. Re: development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration.
    Ziemssen F, Heiduschka P, Schraermeyer U, Tübingen Bevacizumab Study Group.
    Retina; 2007 Oct; 27(8):1154-6; author reply 1156-8. PubMed ID: 18040264
    [No Abstract] [Full Text] [Related]

  • 25. [Risk factors for diabetic complications: Angiogenesis factor].
    Katsura Y.
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():73-8. PubMed ID: 12430210
    [No Abstract] [Full Text] [Related]

  • 26. Pathology beyond neovascularization: new targets in age-related macular degeneration.
    Heier JS.
    Retina; 2009 Jun; 29(6 Suppl):S39-41. PubMed ID: 19553799
    [Abstract] [Full Text] [Related]

  • 27. Results of one-year's treatment with ranibizumab for exudative age-related macular degeneration in a clinical setting.
    Cohen SY, Dubois L, Tadayoni R, Fajnkuchen F, Nghiem-Buffet S, Delahaye-Mazza C, Guiberteau B, Quentel G.
    Am J Ophthalmol; 2009 Sep; 148(3):409-13. PubMed ID: 19477713
    [Abstract] [Full Text] [Related]

  • 28. Time course of morphologic effects on different retinal compartments after ranibizumab therapy in age-related macular degeneration.
    Ahlers C, Golbaz I, Stock G, Fous A, Kolar S, Pruente C, Schmidt-Erfurth U.
    Ophthalmology; 2008 Aug; 115(8):e39-46. PubMed ID: 18675694
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Molecular mechanism for choroidal neovascularization in age-related macular degeneration].
    Ohno-Matsui K.
    Nippon Ganka Gakkai Zasshi; 2003 Nov; 107(11):657-73. PubMed ID: 14661539
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration: promises and pitfalls.
    Csaky K.
    Ophthalmology; 2003 May; 110(5):879-81. PubMed ID: 12750083
    [No Abstract] [Full Text] [Related]

  • 34. Age-related macular degeneration (AMD): pathogenesis and therapy.
    Nowak JZ.
    Pharmacol Rep; 2006 May; 58(3):353-63. PubMed ID: 16845209
    [Abstract] [Full Text] [Related]

  • 35. Negative regulators of angiogenesis: important targets for treatment of exudative AMD.
    Farnoodian M, Wang S, Dietz J, Nickells RW, Sorenson CM, Sheibani N.
    Clin Sci (Lond); 2017 Aug 01; 131(15):1763-1780. PubMed ID: 28679845
    [Abstract] [Full Text] [Related]

  • 36. No efficacious treatment for age-related macular degeneration.
    Roodhooft J.
    Bull Soc Belge Ophtalmol; 2000 Aug 01; 276():83-92. PubMed ID: 10925530
    [Abstract] [Full Text] [Related]

  • 37. The Harvard angiogenesis story.
    Miller JW.
    Surv Ophthalmol; 2014 Aug 01; 59(3):361-4. PubMed ID: 24138892
    [Abstract] [Full Text] [Related]

  • 38. Detection of inducible nitric oxide synthase and vascular endothelial growth factor in choroidal neovascular membranes.
    Hattenbach LO, Falk B, Nürnberger F, Koch FH, Ohrloff C.
    Ophthalmologica; 2002 Aug 01; 216(3):209-14. PubMed ID: 12065859
    [Abstract] [Full Text] [Related]

  • 39. [Current and future trends in gene therapy for diabetic retinopathies].
    Mori K.
    Nihon Rinsho; 2005 Jun 01; 63 Suppl 6():250-5. PubMed ID: 15999715
    [No Abstract] [Full Text] [Related]

  • 40. [Recent findings on the etiopathogenesis of subretinal neovascularization].
    Soubrane G, Courtois Y, Coscas G, Jeanny JC.
    Ophtalmologie; 1990 Jun 01; 4(1):8-12. PubMed ID: 1701235
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.